期刊
JOURNAL OF NEUROSCIENCE
卷 32, 期 47, 页码 16857-+出版社
SOC NEUROSCIENCE
DOI: 10.1523/JNEUROSCI.1858-12.2012
关键词
-
资金
- NIH [P30AG10161, R01AG15819]
- University of Minnesota Medical Foundation
- Collegio Ghislieri (Pavia, Italy)
Amid controversy, the cellular form of the prion protein PrPc has been proposed to mediate oligomeric amyloid-beta (A beta)-induced deficits. In contrast, there is consistent evidence that the Src kinase Fyn is activated by A beta oligomers and leads to synaptic and cognitive impairment in transgenic animals. However, the molecular mechanism by which soluble A beta activates Fyn remains unknown. Combining the use of human and transgenic mouse brain tissue as well as primary cortical neurons, we demonstrate that soluble A beta binds to PrPc at neuronal dendritic spines in vivo and in vitro where it forms a complex with Fyn, resulting in the activation of the kinase. Using the antibody 6D11 to prevent oligomeric A beta from binding to PrPc, we abolished Fyn activation and Fyn-dependent tau hyperphosphorylation induced by endogenous oligomeric A beta in vitro. Finally, we showed that gene dosage of Prnp regulates A beta-induced Fyn/tau alterations. Together, our findings identify a complete signaling cascade linking one specific endogenous A beta oligomer, Fyn alteration, and tau hyperphosphorylation in cellular and animal models modeling aspects of the molecular pathogenesis of Alzheimer's disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据